// App-Quantinova.ai

PB1203 : Fibrinolytic Alterations in a Thrombomodulin-associated Coagulopathy Are Diminished by Coinheritance of a TAFI Mutation

Researchers

Presenter

  • C.S. Whyte

Principal Investigators

  • S. Westbury

  • R.C. Tait

  • N.J. Mutch

  • K. Downes

  • J. Mertens

  • K. Claesen

  • D. Hendriks

  • E. Leishman

  • A. Mumford

Medical Centers

  • University of Aberdeen, Aberdeen Cardiovascular & Diabetes Centre, Aberdeen, United Kingdom

  • University of Bristol, Cellular and Molecular Medicine, Bristol, United Kingdom

  • Glasgow Royal Infirmary, Department of Haematology, Glasgow, United Kingdom

  • University of Cambridge, Cambridge, United Kingdom

  • University of Antwerp, Laboratory of Medical Microbiology, Antwerp, Belgium

Locations

  • United Kingdom

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Tuberculosis

Biomarkers

  • Thrombin-activatable fibrinolysis inhibitor

Drug/Treatment

  • Thrombomodulin alfa

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved